Institutions are working to attract and retain this new group of highly qualified professionals.
Professionals trained in manufacturing and process development in the cell and gene therapy field are in high demand to meet the needs of a rapidly expanding industry. Since the U.S. Food and Drug Administration (FDA) began approving gene and cellular therapies less than a decade ago, more than 40 products have been licensed, with many more currently being explored in clinical trials.1
“If you look at the FDA, the cell therapies approval rate is exponentially increasing every year from CAR T-cell therapies to somatic cell therapies and products,” said Wanxing Cui, MD, PhD, CABP(H), director of the cell therapy manufacturing facility at MedStar Georgetown University Hospital, whose lab does both minimal manipulation and more than minimal manipulation. “Every product approval means there is a ton of staff demand necessary to deliver that product to the patient bedside.”
BACK TO ISSUE
October 2025NEXT STORY
A Time of Reflection
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
President
Meghan Delaney, DO, MPH
Chief Executive Officer
Debra Ben Avram, FASAE, CAE
Chief Communications and Engagement Officer
Julia Zimmerman
Director of Marketing and Communications
Jay Lewis, MPH
Managing Editor
Kendra Y. Mims, MFA
Senior Communications Manager
Drew Case
AABB News
(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.
Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
